Manhattan Associates, Inc. (MANH) Stock Forecast
Data as of May 2, 2026Technology · Current price $139.70 (+1.31%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 15, 2026 | Terry Tillman | Truist Financial | $240.00 | +71.8% |
| Jan 12, 2026 | Guy Hardwick | Barclays | $237.00 | +69.6% |
| Oct 22, 2025 | Clark Wright | D.A. Davidson | $250.00 | +79.0% |
| Oct 22, 2025 | Terry Tillman | Truist Financial | $230.00 | +64.6% |
| Oct 22, 2025 | Brian Peterson | Raymond James | $240.00 | +71.8% |
| Oct 7, 2025 | Guy Hardwick | Barclays | $247.00 | +76.8% |
| May 21, 2025 | Joe Vruwink | Robert W. Baird | $212.00 | +51.8% |
| Apr 23, 2025 | Gil Luria | D.A. Davidson | $200.00 | +43.2% |
| Apr 14, 2025 | Gil Luria | D.A. Davidson | $195.00 | +39.6% |
| Oct 23, 2024 | Brian Peterson | Raymond James | $305.00 | +118.3% |
| Oct 23, 2024 | Gil Luria | D.A. Davidson | $315.00 | +125.5% |
| Oct 22, 2024 | Joe Vruwink | Robert W. Baird | $304.00 | +117.6% |
| Oct 11, 2024 | Terry Tillman | Truist Financial | $310.00 | +121.9% |
| Sep 25, 2024 | George Kurosawa | Citigroup | $287.00 | +105.4% |
| Jul 24, 2024 | Mark Schappel | Loop Capital Markets | $265.00 | +89.7% |
| Jul 24, 2024 | Joe Vruwink | Robert W. Baird | $261.00 | +86.8% |
| May 16, 2024 | Gil Luria | D.A. Davidson | $260.00 | +86.1% |
| Apr 25, 2024 | Gil Luria | D.A. Davidson | $240.00 | +71.8% |
| Apr 15, 2024 | Terry Tillman | Truist Financial | $275.00 | +96.9% |
Top Analysts Covering MANH
MANH vs Sector & Market
| Metric | MANH | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.14 | 2.34 | 2.41 |
| Analyst Count | 14 | 13 | 18 |
| Target Upside | +41.2% | +4072.7% | +14.9% |
| P/E Ratio | 39.13 | 27.89 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $288M | $288M | $289M | 6 |
| 2026-09-30 | $295M | $296M | $299M | 4 |
| 2026-12-31 | $1.14B | $1.15B | $1.16B | 9 |
| 2027-03-31 | $302M | $303M | $304M | 3 |
| 2027-06-30 | $312M | $313M | $314M | 3 |
| 2027-09-30 | $322M | $323M | $324M | 3 |
| 2027-12-31 | $318M | $319M | $320M | 3 |
| 2028-03-31 | $334M | $335M | $336M | 2 |
| 2028-06-30 | $343M | $344M | $345M | 2 |
| 2028-09-30 | $352M | $353M | $354M | 2 |
| 2028-12-31 | $343M | $344M | $345M | 2 |
| 2029-12-31 | $1.48B | $1.49B | $1.51B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $1.29 | $1.31 | $1.33 | 7 |
| 2026-09-30 | $1.43 | $1.43 | $1.45 | 3 |
| 2026-12-31 | $5.27 | $5.35 | $5.40 | 8 |
| 2027-03-31 | $1.37 | $1.38 | $1.38 | 3 |
| 2027-06-30 | $1.49 | $1.49 | $1.50 | 2 |
| 2027-09-30 | $1.57 | $1.57 | $1.58 | 2 |
| 2027-12-31 | $1.52 | $1.53 | $1.53 | 2 |
| 2028-03-31 | $1.53 | $1.53 | $1.54 | 3 |
| 2028-06-30 | $1.65 | $1.65 | $1.66 | 6 |
| 2028-09-30 | $1.73 | $1.73 | $1.74 | 5 |
| 2028-12-31 | $1.62 | $1.62 | $1.63 | 5 |
| 2029-12-31 | $7.85 | $7.94 | $8.03 | 1 |
Frequently Asked Questions
What is the analyst consensus for MANH?
The consensus among 14 analysts covering Manhattan Associates, Inc. (MANH) is Buy with an average price target of $228.67.
What is the highest price target for MANH?
The highest price target for MANH is $315.00, set by Gil Luria at D.A. Davidson on 2024-10-23.
What is the lowest price target for MANH?
The lowest price target for MANH is $195.00, set by Gil Luria at D.A. Davidson on 2025-04-14.
How many analysts cover MANH?
14 analysts have issued ratings for Manhattan Associates, Inc. in the past 12 months.
Is MANH a buy or sell right now?
Based on 14 analyst ratings, MANH has a consensus rating of Buy (2.14/5) with a +41.2% upside to the consensus target of $228.67.
What are the earnings estimates for MANH?
Analysts estimate MANH will report EPS of $1.31 for the period ending 2026-06-30, with revenue estimated at $288M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.